The inclusion of neffy on Express Scripts’ Commercial National Formularies significantly expands access to millions of commercially insured patients, improving availability of life-saving allergy ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--DNA Script, a world leader in Enzymatic DNA Synthesis (EDS) for DNA on demand, has added life sciences veteran Chris Barbazette as Chief Commercial ...
Inclusion of neffy on Express Scripts commercial formularies was effective November 22, 2024 and expands access to patients and caregivers managing Type 1 Allergic Reactions SAN DIEGO, Dec. 19, 2024 ...
Company's immunology franchise demonstrates strong market momentum with preferred status under one of the largest pharmacy benefit managers in the nation IMULDOSA, a biosimilar to STELARA® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback